Moderna and Merck's personalized skin cancer vaccine cleared its first large-scale trial

The mRNA-based vaccine combined with Keytruda reduced melanoma recurrence in more than 1,100 patients whose cancer had been surgically removed [...]

Merck and Mastercard are seeing real agentic AI results. Both say the plumbing came first.

Merck is using AI agents to cut drug discovery cycles by a third and ship compliant marketing materials up to 80% faster — but VP of Digital Platforms Sean Finnerty says the only reason it's wo [...]

mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say

The vaccines are tailor-made to target each patient's unique cancer. [...]

FDA approves at-home pap smear alternative device for cervical cancer screening

The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]

Moderna mRNA flu vaccine bests standard shot in peer-reviewed trial, FDA decision due in August

Results published in the New England Journal of Medicine show the mRNA shot reduced flu illness by about 27% more than a standard-dose vaccine [...]

Moderna and other vaccines stocks are down after the FDA's top vaccine official resigns

Moderna (MRNA) and other vaccine maker stocks plummeted during pre-market trading on Monday amid news from this weekend that the Food and Drug Administration’s (FDA) top vaccine regulator was forced [...]

Engadget Podcast: iPhone 16e review and Amazon's AI-powered Alexa+

The keyword for the iPhone 16e seems to be "compromise." In this episode, Devindra chats with Cherlynn about her iPhone 16e review and try to figure out who this phone is actually for. Also, [...]

FDA approves Moderna's mRNA flu vaccine after initially refusing to review it

After refusing to even review it, the FDA has approved Moderna's mRNA seasonal flu vaccine. [...]

FDA approved Moderna's mRNA flu vaccine after initially refusing to review it

The vaccine, called mFlusiva, is the first mRNA-based flu shot to receive regulatory approval anywhere in the world [...]